News
06-29-2011, 07:21 AM
The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.
More... (http://www.news-medical.net/news/20110629/Patients-scientists-in-different-corners-for-cancer-drug-fight.aspx)
More... (http://www.news-medical.net/news/20110629/Patients-scientists-in-different-corners-for-cancer-drug-fight.aspx)